These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3102256)

  • 21. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes induced by PAF-acether in diacyl and ether phospholipids from guinea-pig alveolar macrophages.
    Bachelet M; Masliah J; Vargaftig BB; Bereziat G; Colard O
    Biochim Biophys Acta; 1986 Sep; 878(2):177-83. PubMed ID: 3092866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites.
    Tessner TG; O'Flaherty JT; Wykle RL
    J Biol Chem; 1989 Mar; 264(9):4794-9. PubMed ID: 2538461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human platelet secreted proteins and prostacyclin production by bovine aortic endothelial cells.
    Poggi A; Niewiarowski S; Stewart GJ; Sobel E; Smith JB
    Proc Soc Exp Biol Med; 1983 Apr; 172(4):543-50. PubMed ID: 6221344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD2 triggering stimulates the formation of platelet-activating factor-acether from alkyl-arachidonoyl-glycerophosphocholine in a human CD4+ T lymphocyte clone.
    Le Gouvello S; Vivier E; Debre P; Thomas Y; Colard O
    J Immunol; 1992 Aug; 149(4):1289-93. PubMed ID: 1354232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
    Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
    Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
    Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
    Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of structural analogues of PAF-acether on platelet desensitization.
    Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J
    Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.
    Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB
    Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between PAF-acether and drugs that stimulate cyclic AMP in guinea-pig alveolar macrophages.
    Bachelet M; Adolfs MJ; Masliah J; Bereziat G; Vargaftig BB; Bonta IL
    Eur J Pharmacol; 1988 Apr; 149(1-2):73-8. PubMed ID: 2840303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes.
    Sperling RI; Robin JL; Kylander KA; Lee TH; Lewis RA; Austen KF
    J Immunol; 1987 Dec; 139(12):4186-91. PubMed ID: 2826583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets.
    Kloprogge E; Mommersteeg M; Akkerman JW
    J Biol Chem; 1986 Aug; 261(24):11071-6. PubMed ID: 3015954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro.
    Michel L; Denizot Y; Thomas Y; Jean-Louis F; Pitton C; Benveniste J; Dubertret L
    J Immunol; 1988 Aug; 141(3):948-53. PubMed ID: 3397536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.
    Jouvin-Marche E; Ninio E; Beaurain G; Tence M; Niaudet P; Benveniste J
    J Immunol; 1984 Aug; 133(2):892-8. PubMed ID: 6736649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.
    McIntyre TM; Zimmerman GA; Satoh K; Prescott SM
    J Clin Invest; 1985 Jul; 76(1):271-80. PubMed ID: 2862164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall.
    Bourgain RH; Maes L; Braquet P; Andries R; Touqui L; Braquet M
    Prostaglandins; 1985 Aug; 30(2):185-97. PubMed ID: 3931178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human endothelial cells are target for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells.
    Heller R; Bussolino F; Ghigo D; Garbarino G; Pescarmona G; Till U; Bosia A
    J Immunol; 1992 Dec; 149(11):3682-8. PubMed ID: 1431139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.
    Heller R; Bussolino F; Calvino R; Ghigo D; Alessio P; Todde R; Fruttero R; Pescarmona G; Gasco A; Till U
    Agents Actions; 1993 Nov; 40(3-4):157-65. PubMed ID: 7517616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.